Scholarlink

<p>Knee osteoarthritis (KOA), a degenerative disorder characterized by compromised physical function and diminished quality of life, imposes substantial burdens on patients, families, healthcare systems, and society. Stepwise therapeutic approach, initiated after first-line non-pharmacological interventions such as weight loss, exercise, and physical therapy, remains the cornerstone of KOA management, with glucocorticoids (GCs) injections widely adopted for rapid and effective pain relief. However, the absence of comprehensive guidelines or consensus documents specifically addressing GC applications has led to inconsistent clinical practices. To address this gap, a multidisciplinary panel of Chinese KOA experts developed this consensus through iterative discussions, synthesizing current evidence and domestic clinical experience. The final document outlines 22 recommendations encompassing GC selection, target population, timing of administration, dosing frequency and contraindications, aiming to standardize evidence-based GC utilization in KOA care.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Expert consensus on glucocorticoids injection for knee osteoarthritis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月8日

查看全文
  • Ye Huang,
  • Peilai Liu

摘要

Knee osteoarthritis (KOA), a degenerative disorder characterized by compromised physical function and diminished quality of life, imposes substantial burdens on patients, families, healthcare systems, and society. Stepwise therapeutic approach, initiated after first-line non-pharmacological interventions such as weight loss, exercise, and physical therapy, remains the cornerstone of KOA management, with glucocorticoids (GCs) injections widely adopted for rapid and effective pain relief. However, the absence of comprehensive guidelines or consensus documents specifically addressing GC applications has led to inconsistent clinical practices. To address this gap, a multidisciplinary panel of Chinese KOA experts developed this consensus through iterative discussions, synthesizing current evidence and domestic clinical experience. The final document outlines 22 recommendations encompassing GC selection, target population, timing of administration, dosing frequency and contraindications, aiming to standardize evidence-based GC utilization in KOA care.